VistaPharm, Inc. is recalling 14,244 bottles of Nystatin Oral Suspension, USP (100,000 units per mL), a bubblegum-flavored liquid medication used to treat fungal infections. This recall was initiated because testing for one specific lot showed results for an impurity that exceeded the approved safety and quality specifications. Approximately 14,244 bottles (16 fl. oz. size) were distributed nationwide to pharmacies and healthcare providers.
The product failed to meet the required specifications for impurities and degradation products. While the specific health risk level is categorized as low, impurities in medication can affect the drug's safety, potency, and effectiveness over time.
Healthcare consultation and pharmacy refund
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.